Table 3 Multivariate Cox regression (Survival)

Model 1

MSKCC - Risk Group

   Favourable

   Intermediate

   Poor

Model 2

Metastatic sites

   1

   >1

Time between diagnosis/surgery and Sunitinib initiation

   <= 12 months

   >12 months

Performance Status

   <= 1

   >1

Model 3

4-Groups

   0 risk

   1 risk

   2 risk

   3 risk

Model 4

3-Groups

   0 or 1 risk

   2 risk

   3 risk

Model 5

2-Groups

   0 or 1 risk

   2 or 3 risk